Guard Wire Plus Guard Wire Plus Export Aspiration

  • Slides: 35
Download presentation

Guard. Wire Plus™ Guard. Wire Plus Export Aspiration Catheter Inflation System: Micro. Seal® Adapter

Guard. Wire Plus™ Guard. Wire Plus Export Aspiration Catheter Inflation System: Micro. Seal® Adapter & EZ Flator™

Accu. Net Polyurethane 115 microns 3. 5 -3. 7 F

Accu. Net Polyurethane 115 microns 3. 5 -3. 7 F

Angioguard™ XP / RX Cordis Polyurethane Crossing profile: 3. 2 -3. 9 Fr 100μm

Angioguard™ XP / RX Cordis Polyurethane Crossing profile: 3. 2 -3. 9 Fr 100μm

GORE® Embolic Filter Gore Mesh-Covered Carotid Stent Diamond Frame e. PTFE Filter Media with

GORE® Embolic Filter Gore Mesh-Covered Carotid Stent Diamond Frame e. PTFE Filter Media with 100 -Micron Pores and Hydrophilic Heparin Coating 3. 2 Fr crossing profile combines the flexible properties of a traditional open-cell, nitinol stent design with a 500 micron pore size e. PTFE lattice which offers the plaque retention and stabilization benefits traditionally seen in a closed cell stent design. Additionally, the permanently bound heparin may offer a local advantage seen with other Gore devices that utilize bound heparin.

CGUARD™ Embolic Prevention System (EPS), Inspire. MD, 101 patients (54. 4% symptomatic) 0. 9%

CGUARD™ Embolic Prevention System (EPS), Inspire. MD, 101 patients (54. 4% symptomatic) 0. 9% of minor stroke at 30 -days follow-up, no major events). � CGuard material: Nitinol � Micro. Net material: Polyethylene Terephthalate (PET) � Dual Layer Design � Open cell stent platform wrapped in Micro. Net mesh � Micro. Net TM for continuous embolic prevention Micro. Net (“pore” is only 150 -180 microns) � Smart. Fit. TM Technology eliminates need for tapered version

Filter. Wire EZ Boston Eccentric Loop Design Polyurethane Crossing profile: 3. 2 Fr 110µM

Filter. Wire EZ Boston Eccentric Loop Design Polyurethane Crossing profile: 3. 2 Fr 110µM

Spider. FX COVIDIEN ΑΝΕΞΑΡΤΗΤΟ ΣΥΡΜΑ Eccentric design heparin coated nitinol 50 mm – 3.

Spider. FX COVIDIEN ΑΝΕΞΑΡΤΗΤΟ ΣΥΡΜΑ Eccentric design heparin coated nitinol 50 mm – 3. 2 F

Fiber Net® PET (Polyethylene terephthalate) Fibers 40µm 2. 4 -2. 9 Fr Καθετήρας απόσυρσης

Fiber Net® PET (Polyethylene terephthalate) Fibers 40µm 2. 4 -2. 9 Fr Καθετήρας απόσυρσης = αναρόφησης

W. L. Gore & Associates, Inc. Requires complete Circle of Willis Complicated Profile 9

W. L. Gore & Associates, Inc. Requires complete Circle of Willis Complicated Profile 9 F 3. 7% groin hematoma in trial No need to “touch” lesion prior to stenting Requires venous access Must work on roadmap as physician cannot inject contrast Intolerance to reverse flow and occlusion

 • “Lesion is crossed after patient is completely protected. ” • GW of

• “Lesion is crossed after patient is completely protected. ” • GW of choice to cross the lesion • Intolerance to occlusion • External carotid balloon jailed between the artery and the stent. • No need to aspirate with filter • «ΕΠΙΚΙΝΔΥΝΕΣ» ΒΛΑΒΕΣ • ΑΝΑΤΟΜΙΚΕΣ ΔΥΣΚΟΛΙΕΣ

Συνδυασμός τραχηλικής προσπέλασης και αναστροφής της ροής The ENROUTE transcarotid neuroprotection (NPS) and stent

Συνδυασμός τραχηλικής προσπέλασης και αναστροφής της ροής The ENROUTE transcarotid neuroprotection (NPS) and stent (TSS) systems Silk Road Medical, Inc.

΄΄With the Enroute transcarotid NPS, we now have CEA-like neuroprotection and a simplified procedure

΄΄With the Enroute transcarotid NPS, we now have CEA-like neuroprotection and a simplified procedure that can fulfill the promise of CAS. ”

Evidence overview: benefit of cerebral protection devices during carotid artery stenting In conclusion, all

Evidence overview: benefit of cerebral protection devices during carotid artery stenting In conclusion, all currently available EPDs still result in some degree of cerebral embolization. No solid recommendation for a particular type of EPDs, if any, can be derived from literature J Cardiovasc Surg (Torino). 2017 Apr; 58(2): 170 -177. doi: 10. 23736/S 00219509. 16. 09848 -7. Epub 2016 Dec 22 In patients undergoing CAS, both D-EPD and P-EPD provide similar levels of protection from peri-procedural stroke and 30 days mortality. Catheter Cardiovasc Interv. 2017 Apr; 89(5): 923 -931. doi: 10. 1002/ccd. 26842. Epub 2016 Nov 12.